PharmaEssentia Corporation

Total Valuation

PharmaEssentia Corporation carries a market capitalization of 537.41B, placing it among publicly traded companies globally. Its enterprise value stands at 149.17B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

PharmaEssentia Corporation currently has 333.27M shares outstanding.

Valuation Ratios

PharmaEssentia Corporation trades at a trailing price-to-earnings ratio of 41.72. The price-to-sales ratio is 13.38, and the price-to-book ratio stands at 21.71.

Enterprise Valuation

On an enterprise value basis, PharmaEssentia Corporation trades at an EV/EBITDA multiple of 42.90 and an EV/FCF ratio of 34.28. The EV/Sales ratio of 11.81 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 42.90 provides insight into valuation relative to core operating earnings.

Financial Position

PharmaEssentia Corporation maintains a current ratio of 7.71, meaning it holds 7.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 3.31, indicating elevated leverage, while an interest coverage ratio of 138.58 demonstrates strong ability to service its debt obligations.

Financial Efficiency

Taxes

Over the trailing twelve months, PharmaEssentia Corporation has paid -761.26M in income taxes, reflecting an effective tax rate of 31.84.

Stock Price Statistics

PharmaEssentia Corporation's stock has gained approximately 203.13201% over the past 52 weeks. The 50-day moving average sits at 912.72, while the 200-day moving average is 664.89.

Income Statement

Over the trailing twelve months, PharmaEssentia Corporation generated 12.63B in revenue and converted that into 4.05B in net income, yielding earnings per share of 11.00. EBITDA reached 3.48B, while operating income came in at 3.48B.

Balance Sheet

PharmaEssentia Corporation holds 20.80B in cash and equivalents against 944.51M in total debt, resulting in a net debt position of -20.73B. Total book value stands at 7.79B, with working capital of 22.43B providing operational flexibility.

Cash Flow

PharmaEssentia Corporation produced 3.11B in operating cash flow over the past twelve months. After subtracting -1.21B in capital expenditures, free cash flow totaled 1.89B - equivalent to 5.53 per share.

Margins

PharmaEssentia Corporation operates with a gross margin of 88.16, reflecting its pricing power and cost economics. The operating margin of 27.52 and net profit margin of 32.06 provide insight into operational efficiency.

Dividends & Yields

Stock Splits

PharmaEssentia Corporation's most recent stock split took place on July 9, 2026 with a 1000:1109 split ratio.

Scores

PharmaEssentia Corporation posts an Altman Z-Score of 25.55, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.